| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/18/2023 | 16.55% | Barclays | $18 → $15 | Maintains | Equal-Weight |
| 05/09/2023 | 39.86% | Barclays | $17 → $18 | Maintains | Equal-Weight |
| 04/03/2023 | 32.09% | Barclays | → $17 | Upgrades | Underweight → Equal-Weight |
| 03/06/2023 | 16.55% | Citigroup | $13.5 → $15 | Maintains | Neutral |
| 01/04/2023 | 16.55% | Morgan Stanley | $18 → $15 | Maintains | Equal-Weight |
| 11/01/2022 | 39.86% | Morgan Stanley | $17 → $18 | Maintains | Equal-Weight |
| 09/26/2022 | 32.09% | Morgan Stanley | $16 → $17 | Maintains | Equal-Weight |
| 08/01/2022 | 24.32% | Morgan Stanley | $15 → $16 | Maintains | Equal-Weight |
| 07/13/2022 | 16.55% | Morgan Stanley | → $15 | Upgrades | Underweight → Equal-Weight |
| 06/14/2022 | 55.4% | Evercore ISI Group | → $20 | Upgrades | In-Line → Outperform |
| 05/02/2022 | 55.4% | Morgan Stanley | $18 → $20 | Maintains | Underweight |
| 05/02/2022 | 55.4% | Evercore ISI Group | $16 → $20 | Downgrades | Outperform → In-Line |
| 05/02/2022 | 32.09% | Barclays | $12 → $17 | Maintains | Underweight |
| 04/11/2022 | 39.86% | Morgan Stanley | $11 → $18 | Maintains | Underweight |
| 12/07/2021 | -6.76% | Morgan Stanley | $11 → $12 | Maintains | Underweight |
| 08/03/2021 | -14.53% | Morgan Stanley | $10 → $11 | Maintains | Underweight |
| 07/09/2021 | -22.3% | Morgan Stanley | $8 → $10 | Maintains | Underweight |
| 05/28/2021 | -22.3% | Barclays | $12 → $10 | Downgrades | Equal-Weight → Underweight |
| 03/25/2021 | -37.84% | Morgan Stanley | $6 → $8 | Maintains | Underweight |
| 01/04/2021 | — | Evercore ISI Group | Upgrades | In-Line → Outperform | |
| 12/15/2020 | — | Citigroup | Upgrades | Sell → Neutral | |
| 07/08/2020 | -80.57% | Morgan Stanley | $2 → $2.5 | Maintains | Underweight |
| 07/06/2020 | -76.69% | Evercore ISI Group | → $3 | Upgrades | Underperform → In-Line |
| 05/19/2020 | -84.46% | Morgan Stanley | $1 → $2 | Maintains | Underweight |
| 05/04/2020 | -72.8% | Stifel | $3 → $3.5 | Maintains | Buy |
| 03/19/2020 | -84.46% | Barclays | $4 → $2 | Upgrades | Underweight → Equal-Weight |
| 03/16/2020 | -92.23% | Morgan Stanley | $7 → $1 | Maintains | Underweight |
| 11/05/2019 | — | Johnson Rice | Downgrades | Accumulate → Hold | |
| 10/31/2019 | — | Barclays | Downgrades | Equal-Weight → Underweight | |
| 10/30/2019 | -57.26% | Piper Sandler | $10.5 → $5.5 | Downgrades | Overweight → Neutral |
| 10/22/2019 | 16.55% | B. Riley Securities | $20 → $15 | Maintains | Buy |
| 10/07/2019 | -22.3% | Morgan Stanley | $15 → $10 | Maintains | Underweight |
| 10/01/2019 | — | Cowen & Co. | Downgrades | Outperform → Market Perform | |
| 09/30/2019 | -14.53% | Barclays | $14 → $11 | Maintains | Equal-Weight |
| 09/23/2019 | -6.76% | Citigroup | $10 → $12 | Maintains | Neutral |
| 09/10/2019 | — | RF Lafferty | Downgrades | Buy → Hold | |
| 09/05/2019 | -22.3% | Citigroup | $13.5 → $10 | Maintains | Neutral |
| 07/12/2019 | 16.55% | Morgan Stanley | $14 → $15 | Maintains | Underweight |
| 01/15/2019 | 16.55% | Barclays | $20 → $15 | Downgrades | Overweight → Equal-Weight |
| 10/24/2018 | 39.86% | Credit Suisse | $21 → $18 | Maintains | Outperform |
| 10/24/2018 | 55.4% | Barclays | $30 → $20 | Maintains | Overweight |
| 10/24/2018 | 16.55% | Citigroup | $22 → $15 | Maintains | Neutral |
| 10/17/2018 | 55.4% | Jefferies | → $20 | Downgrades | Buy → Hold |
| 10/11/2018 | — | Morgan Stanley | Downgrades | Equal-Weight → Underweight | |
| 10/10/2018 | 86.48% | Stifel | $26 → $24 | Maintains | Buy |
| 09/20/2018 | — | RBC Capital | Downgrades | Outperform → Sector Perform | |
| 09/14/2018 | 86.48% | Citigroup | $28 → $24 | Maintains | Neutral |
| 09/11/2018 | 102.02% | Stifel | → $26 | Initiates Coverage On | → Buy |
| 09/06/2018 | 102.02% | B. Riley Securities | $36 → $26 | Maintains | Buy |
| 08/28/2018 | 125.33% | Credit Suisse | $38 → $29 | Maintains | Outperform |
| 08/27/2018 | 187.49% | RF Lafferty | $41 → $37 | Maintains | Buy |
| 08/01/2018 | 195.26% | Credit Suisse | $36 → $38 | Maintains | Outperform |
| 07/27/2018 | 171.95% | Keybanc | $40 → $35 | Maintains | Overweight |
What is the target price for US Silica Holdings (SLCA)?
The latest price target for US Silica Holdings (NYSE: SLCA) was reported by Barclays on July 18, 2023. The analyst firm set a price target for $15.00 expecting SLCA to rise to within 12 months (a possible 16.55% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for US Silica Holdings (SLCA)?
The latest analyst rating for US Silica Holdings (NYSE: SLCA) was provided by Barclays, and US Silica Holdings maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for US Silica Holdings (SLCA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of US Silica Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for US Silica Holdings was filed on July 18, 2023 so you should expect the next rating to be made available sometime around July 18, 2024.
Is the Analyst Rating US Silica Holdings (SLCA) correct?
While ratings are subjective and will change, the latest US Silica Holdings (SLCA) rating was a maintained with a price target of $18.00 to $15.00. The current price US Silica Holdings (SLCA) is trading at is $12.87, which is out of the analyst's predicted range.